Title Author Journal name Search by Year No Title / Author Journal Name Year 395 A naturally truncated NS1 protein of influenza A virus impairs its interferon-antagonizing activity and thereby confers attenuation in vitro.Lee J, Park JH, Min JY. Archives of Virology. 2017 394 Identification of Aminopyrimidine-Sulfonamides as Potent Modulators of Wag31-mediated Cell Elongation in MycobacteriaSingh V, Dhar N, Pato J, Kolly GS, Kordulakova J, Forbak M, Evans JC, Szekely R, Rybniker J, Palcekova Z, Zemanova J, Santi I,... Mol Microbiol 2017 393 Evaluation of Parameters Impacting Drug Susceptibility in Intracellular Trypanosoma cruzi Assay ProtocolsGyongseon Yang, Nakyung Lee, Jean-Robert Ioset, Joo Hwan No. SLAS Discov. 2017 392 Synthesis and structure-activity studies of side chain analogues of the anti-tubercular agent, Q203.Kang S, Kim YM, Kim RY, Seo MJ, No Z, Nam K, Kim S, Kim J. Eur J Med Chem. 2017 391 High-Content Screening of Raw Actinomycete Extracts for the Identification of Antituberculosis ActivitiesHeo J, Nam J, Jang J, Shum D, Radu C, Cheng J, Lee H, Suh JW, Delorme V SLAS Discov. 2017 390 Regulation of kynurenine biosynthesis during influenza virus infection.Gaelings L, Soderholm S, Bugai A, Fu Y, Nandania J, Schepens B, Lorey MB, Tynell J, Vande Ginste L, Le Goffic R, Miller MS, Kui... FEBS J. 2017 389 CD133 confers cancer stem-like cell properties by stabilizing EGFR-AKT signaling in hepatocellular carcinomaJang JW, Song Y, Kim SH, Kim JS, Kim KM, Choi EK, Kim J, Seo HR Cancer Lett. 2017 388 Obatoclax, saliphenylhalamide and gemcitabine inhibit Zika virus infection in vitro and differentially affect cellular signaling, transcription and metabolism.Kuivanen S, Bespalov MM, Nandania J, Ianevski A, Velagapudi V, De Brabander JK, Kainov DE, Vapalahti O. Antiviral Res. 2017 387 Sulfasalazine attenuates evading anticancer response of CD133-positive hepatocellular carcinoma cells.Song Y, Jang J, Shin TH, Bae SM, Kim JS, Kim KM, Myung SJ, Choi EK, Seo HR. J Exp Clin Cancer Res 2017 386 Acid phosphatase 2 (ACP2) is required for membrane fusion during influenza virus entry.Lee JH, Kim JH, Son KD, Pham Hung d’Alexandry d’Orengiani AL, Min JY* Scientific Reports. 2017 11 12 13 14 15